Valuation (47%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -60.85 | 31.27 |
PEG Ratio (TTM) | -1.81 | -0.98 |
P/S Ratio (TTM) | 1.49 | 4.70 |
P/B Ratio (TTM) | 1.86 | 6.09 |
P/FCF Ratio (TTM) | 77.55 | 34.13 |
Price to 5YR AVG Earnings Ratio | 34.33 | 46.88 |
Price to 5YR AVG FCF Ratio | 20.04 | 52.82 |
Profitability (5%) |
Company | Industry |
---|---|---|
ROA (TTM) | -1.29% | 8.78% |
ROE (TTM) | -3.02% | 21.57% |
Net Profit Margin (TTM) | -2.46% | 11.64% |
ROIC 5YR AVG | 6.95% | 20.58% |
Growth (15%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -584.91% | -1.86% | -14.62% |
Revenue | 2.24% | -4.32% | 0.45% |
Net Income | -587.29% | -2.37% | -14.99% |
Cash Flow | 260.50% | -10.22% | -7.37% |
Health (49%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.28 | 1.72 |
Quick Ratio (TTM) | 1.35 | 1.15 |
D/E Ratio (TTM) | 0.88 | 0.63 |
Interest Coverage (TTM) | 1.78 | 17.05 |
Piotroski F-Score | 4 | 7 |
Altman Z-Score | 2.32 | 5.32 |
LTL to 5YR AVG FCF | 10.66 | 6.08 |
Shares Outstanding Growth 5YR AVG | -0.48% | 0.55% |